A Novel Competitive Binding Screening Assay Reveals Sennoside B as a Potent Natural Product Inhibitor of TNF-α

Natural products (NPs) have played a significant role in drug discovery for diverse diseases, and numerous attempts have been made to discover promising NP inhibitors of tumor necrosis factor α (TNF-α), a major therapeutic target in autoimmune diseases. However, NP inhibitors of TNF-α, which have th...

Full description

Bibliographic Details
Main Authors: Lei Peng, Prasannavenkatesh Durai, Keunwan Park, Jeong Joo Pyo, Yongsoo Choi
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:Biomedicines
Subjects:
Online Access:https://www.mdpi.com/2227-9059/9/9/1250
_version_ 1797520117011054592
author Lei Peng
Prasannavenkatesh Durai
Keunwan Park
Jeong Joo Pyo
Yongsoo Choi
author_facet Lei Peng
Prasannavenkatesh Durai
Keunwan Park
Jeong Joo Pyo
Yongsoo Choi
author_sort Lei Peng
collection DOAJ
description Natural products (NPs) have played a significant role in drug discovery for diverse diseases, and numerous attempts have been made to discover promising NP inhibitors of tumor necrosis factor α (TNF-α), a major therapeutic target in autoimmune diseases. However, NP inhibitors of TNF-α, which have the potential to be developed as new drugs, have not been reported for over a decade. To facilitate the search for new promising inhibitors of TNF-α, we developed an efficient competitive binding screening assay based on analytical size exclusion chromatography coupled with liquid chromatography-tandem mass spectrometry. Application of this screening method to the NP library led to the discovery of a potent inhibitor of TNF-α, sennoside B, with an IC<sub>50</sub> value of 0.32 µM in TNF-α induced HeLa cell toxicity assays. Surprisingly, the potency of sennoside B was 5.7-fold higher than that of the synthetic TNF-α inhibitor SPD304. Molecular docking was performed to determine the binding mode of sennoside B to TNF-α. In conclusion, we successfully developed a novel competition binding screening method to discover small molecule TNF-α inhibitors and identified the natural compound sennoside B as having exceptional potency.
first_indexed 2024-03-10T07:52:17Z
format Article
id doaj.art-6d92d5c3a0d64d8687436d4089a23afc
institution Directory Open Access Journal
issn 2227-9059
language English
last_indexed 2024-03-10T07:52:17Z
publishDate 2021-09-01
publisher MDPI AG
record_format Article
series Biomedicines
spelling doaj.art-6d92d5c3a0d64d8687436d4089a23afc2023-11-22T12:09:16ZengMDPI AGBiomedicines2227-90592021-09-0199125010.3390/biomedicines9091250A Novel Competitive Binding Screening Assay Reveals Sennoside B as a Potent Natural Product Inhibitor of TNF-αLei Peng0Prasannavenkatesh Durai1Keunwan Park2Jeong Joo Pyo3Yongsoo Choi4School of Chemistry and Chemical Engineering, Qiqihar University, Qiqihar 161006, ChinaNatural Product Informatics Research Center, Korea Institute of Science and Technology (KIST), Gangneung 25451, KoreaNatural Product Informatics Research Center, Korea Institute of Science and Technology (KIST), Gangneung 25451, KoreaNatural Product Research Center, Korea Institute of Science and Technology (KIST), Gangneung 25451, KoreaNatural Product Research Center, Korea Institute of Science and Technology (KIST), Gangneung 25451, KoreaNatural products (NPs) have played a significant role in drug discovery for diverse diseases, and numerous attempts have been made to discover promising NP inhibitors of tumor necrosis factor α (TNF-α), a major therapeutic target in autoimmune diseases. However, NP inhibitors of TNF-α, which have the potential to be developed as new drugs, have not been reported for over a decade. To facilitate the search for new promising inhibitors of TNF-α, we developed an efficient competitive binding screening assay based on analytical size exclusion chromatography coupled with liquid chromatography-tandem mass spectrometry. Application of this screening method to the NP library led to the discovery of a potent inhibitor of TNF-α, sennoside B, with an IC<sub>50</sub> value of 0.32 µM in TNF-α induced HeLa cell toxicity assays. Surprisingly, the potency of sennoside B was 5.7-fold higher than that of the synthetic TNF-α inhibitor SPD304. Molecular docking was performed to determine the binding mode of sennoside B to TNF-α. In conclusion, we successfully developed a novel competition binding screening method to discover small molecule TNF-α inhibitors and identified the natural compound sennoside B as having exceptional potency.https://www.mdpi.com/2227-9059/9/9/1250tumor necrosis factor αnatural productssennoside Banalytical size exclusion chromatographyliquid chromatography-tandem mass spectrometry
spellingShingle Lei Peng
Prasannavenkatesh Durai
Keunwan Park
Jeong Joo Pyo
Yongsoo Choi
A Novel Competitive Binding Screening Assay Reveals Sennoside B as a Potent Natural Product Inhibitor of TNF-α
Biomedicines
tumor necrosis factor α
natural products
sennoside B
analytical size exclusion chromatography
liquid chromatography-tandem mass spectrometry
title A Novel Competitive Binding Screening Assay Reveals Sennoside B as a Potent Natural Product Inhibitor of TNF-α
title_full A Novel Competitive Binding Screening Assay Reveals Sennoside B as a Potent Natural Product Inhibitor of TNF-α
title_fullStr A Novel Competitive Binding Screening Assay Reveals Sennoside B as a Potent Natural Product Inhibitor of TNF-α
title_full_unstemmed A Novel Competitive Binding Screening Assay Reveals Sennoside B as a Potent Natural Product Inhibitor of TNF-α
title_short A Novel Competitive Binding Screening Assay Reveals Sennoside B as a Potent Natural Product Inhibitor of TNF-α
title_sort novel competitive binding screening assay reveals sennoside b as a potent natural product inhibitor of tnf α
topic tumor necrosis factor α
natural products
sennoside B
analytical size exclusion chromatography
liquid chromatography-tandem mass spectrometry
url https://www.mdpi.com/2227-9059/9/9/1250
work_keys_str_mv AT leipeng anovelcompetitivebindingscreeningassayrevealssennosidebasapotentnaturalproductinhibitoroftnfa
AT prasannavenkateshdurai anovelcompetitivebindingscreeningassayrevealssennosidebasapotentnaturalproductinhibitoroftnfa
AT keunwanpark anovelcompetitivebindingscreeningassayrevealssennosidebasapotentnaturalproductinhibitoroftnfa
AT jeongjoopyo anovelcompetitivebindingscreeningassayrevealssennosidebasapotentnaturalproductinhibitoroftnfa
AT yongsoochoi anovelcompetitivebindingscreeningassayrevealssennosidebasapotentnaturalproductinhibitoroftnfa
AT leipeng novelcompetitivebindingscreeningassayrevealssennosidebasapotentnaturalproductinhibitoroftnfa
AT prasannavenkateshdurai novelcompetitivebindingscreeningassayrevealssennosidebasapotentnaturalproductinhibitoroftnfa
AT keunwanpark novelcompetitivebindingscreeningassayrevealssennosidebasapotentnaturalproductinhibitoroftnfa
AT jeongjoopyo novelcompetitivebindingscreeningassayrevealssennosidebasapotentnaturalproductinhibitoroftnfa
AT yongsoochoi novelcompetitivebindingscreeningassayrevealssennosidebasapotentnaturalproductinhibitoroftnfa